| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 4XG66BMN0D |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | C-C chemokine receptor type 2 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cardiovascular Diseases | 2 | D002318 | ClinicalTrials |
| Diabetic Nephropathies | 2 | D003928 | ClinicalTrials |
| Atherosclerosis | 2 | D050197 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3707228 |
| FDA SRS | 4XG66BMN0D |
CONTENTS